SelectQuote Q4 FY2024 revenue $307M, Adj EBITDA $14.4M; FY2025 Adj EBITDA guidance $90-120M

SelectQuote, Inc.

Q4 revenue $307.2M (up from $221.8M YoY); net loss narrowed to $31.0M from $47.8M.
Q4 Adjusted EBITDA $14.4M vs. ($5.8M) YoY; FY2024 Adj EBITDA $117.0M (up from $74.3M).
Senior segment Q4 revenue $114.1M, Adj EBITDA $27.9M; approved Medicare Advantage policies 107,272.
Healthcare Services Q4 revenue $145.2M, Adj EBITDA $0.9M; ~82,000 SelectRx members.
FY2025 guidance: revenue $1.4-1.5B, net loss $42M-$6M, Adj EBITDA $90-120M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.